Abstract
Experimental and clinical data strongly suggests that nitric oxide (NO) plays a pivotal role in migraine. This is also supported by studies of migraine induced by substances that release NO. NO is synthesized from L-arginine by endothelial NO synthase (NOS). Asymmetric dimethylarginine (ADMA) is the major endogenous competitive inhibitor of NOS. Symmetric dimethylarginine (SDMA) is an inactive stereoisomer of ADMA. It may reduce NO production by competing with arginine for cellular uptake. The aim of this study was to measure the levels of ADMA, SDMA and L-arginine in migraine patients during the interictal period. One hundred migraine patients and 100 healthy volunteers were recruited. The patients were in the interictal period and classified into two groups as having migraine with aura and migraine without aura. Their serum ADMA, SDMA and L-arginine levels were measured by high-performance liquid chromotography (HPLC) method. ADMA, SDMA and L-arginine levels were significantly higher in migraine patients compared to the control group. But there was no difference between the patients with and without aura. These results suggest that NOS inhibitors and L-arginine/NO pathway plays an important role in migraine pathopysiology.
References
Buse DC, Manack AN, Fanning KM, Serrano D, Reed ML, Turkel CC, Lipton RB (2012) Chronic migraine prevelance, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study. Headache 52:1456–1470
Van der Kuy PH, Lohman JJ (2003) The role of nitric oxide in vascular headache. Pharm World Sci 25:146–151
Olesen J, Iversen HK, Thomsen LL (1993) Nitric oxide supersensitivity: a possible molecular mechanism of migraine pain. Neuroreport 4:1027–1030
Christiansen I, Thomsen LL, Daugaard D, Urich V, Olesen J (1999) Glyceryl trinitrate induces attacks of migraine without aura in sufferers of migraine with aura. Cephalalgia 19:660–667
Böger R (2004) Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the “L-arginine paradox” and acts as a novel cardiovascular risk factor. J Nutr 134:2842S–2847S
Teerlink T, Nijveldt RJ, Jong S, van Leeuwen PA (2002) Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. Anal Biochem 303:131–137
Böger RH, Bode-Böger SM, Szuba A, Tsao PS, Chan JR, Tangphao O, Blaschke TF, Cooke JP (1998) Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 98:1842–1847
Headache Classification Subcommittee of the International Headache Society (2004) The International classification of headache disorders, 2nd edn. Cephalalgia 24(Suppl. 1):9–160
Tran CT, Leiper JM, Vallance P (2003) The DDAH/ADMA/NOS pathway. Atheroscler Suppl 4:33–40
Costa C, Tozzi A, Rainero I, Cupini LM, Calabresi P, Ayata C, Sarchielli P (2013) Cortical spreading depression as a target for anti-migraine agents. J Headache Pain 14:62. doi:10.1186/1129-2377-14-62
Kruit MC, Launer LJ, Ferrari MD, van Buchem MA (2005) Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study. Brain 128:2068–2077
Spierings EL (2003) Pathogenesis of the migraine attacks. Clin J Pain 19:255–262
Read SJ, Smith MI, Hunter AJ, Parsons AA (1997) The dynamics of nitric oxide release measured directly and in real time following repeated waves of cortical spreading depression in the anaesthetised cat. Neurosci Lett 232:127–130
Obrenovitch TP, Urenjak J, Wang M (2002) Nitric oxide formation during cortical spreading depression is critical for rapid subsequent recovery of ionic hemostasis. J Cereb Blood Flow Metab 22:680–688
Greco R, Ferrigno A, Demartini C, Zanaboni A, Mangione AS, Blandini F et al (2015) Evaluation of ADMA-DDAH-NOS axis in specific brain areas following nitroglycerin administration: study in an animal model of migraine. J Headache and Pain 16:560. doi:10.1186/s10194-015-0560-2
Uzar E, Evliyaoglu O, Toprak G, Acar A, Yücel Y, Calisir T, Cevik MU, Tasdemir N (2011) Increased asymmetric dimethylarginine and nitric oxide levels in patients with migraine. J Headache Pain 12:239–243
Gruber HJ, Bernecker J, Lechner A, Weiss S, Wallner-Blazek M, Meinitzer A et al (2010) Increased nitric oxide stress is associated with migraine. Cephalalgia 30:486–492
Guldiken B, Demir M, Guldiken S, Turgut N, Ozkan H, Kabayel L, Tugrul A (2009) Asymmetric dimethylarginine and nitric oxide levels in migraine during the interictal period. J Clin Neurosci 16:672–674
Jiménez Caballero PE, Muňoz Escudero F (2013) Peripheral endothelial function and arterial stiffness in patients with chronic migraine: a case-control study. J Headache Pain 14:8. doi:10.1186/1129-2377-14-8
Olesen J (2008) The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache. Pharmacol Ther 12:157–171
Thomsen LL, Kruuse C, Iversen HK, Olesen J (1994) A nitric oxide donor (nitroglycerine) triggers genuine migraine attacks. Eur J Neurol 1:73–80
Eid HM, Arnesen H, Hjerkinn EM, Lyberg T, Seljeflot I (2004) Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine. Metabolism 53:1574–1579
Zahavi I, Chagnac A, Hering R, Davidovich S, Kuritzky A (1984) Prevelance of Raynaud’s phenomen in patients with migraine. Arch Intern Med 144:742–744
Katsarava Z, Weimar C (2010) Migraine and stroke. J Neurol Sci 299:42–44
Sacco S, Kurth T (2014) Migraine and the risk for stroke and cardiovascular disease. Curr Cardiol Rep 16:524. doi:10.1007/s11886-014-0524-1
Guegan-Massardier E, Lucas C (2013) Migraine and vascular risk. Rev Neurol (Paris) 169:397–405
Abanoz Y, Gülen Abanoz Y, Gündüz A, Uludüz D, İnce B, Yavuz B, Göksan B (2017) Migraine as a risk factor for young patients with ischemic stroke : a case-control study. Neurol Sci 38:611–617
Hu X, Zhou Y, Zhou H, Peng C (2017) Migraine and the risk of stroke: an updated meta-analysis of prospective cohort studies. Neurol Sci 38:33–40
Xiong Y, Yuan LW, Deng HW, Li YJ, Chen BM (2001) Elevated serum endogenous inhibitors of nitric oxide synthase and endothelial dysfunction in aged rats. Clin Exp Pharmacol Physiol 28:842–847
Bode-Boger SM, Muke J, Surdacki A (2003) Oral L-arginine improves endothelial function in healthy individuals older than 70 years. Vasc Med 8:77–88
Cooke JP (2004) Asymmetrical dimethylarginine the Über marker? Circulation 109:1813–1818
D’andrea G, Cananzi AR, Perini F, Alecci M, Zamberlan F, Hasselmark L, Welch KM (1994) Decreased collagen-induced platelet aggregation and increased platelet arginine levels in migraine: a possible link with the NO pathway. Cephalalgia 14:352–356
Chen JQ, Zeng YM, Dai TJ, Tang Q (2015) Intrathecal L-arginine reduces the antinociception of sevoflurane in formalin-induced pain in rats. Neurosci Lett 590:156–160
Deng YK, Ding JF, Liu J, Yang YY (2015) Analgesic effects of melatonin on post-herpetic neuralgia. Int J Clin Exp Med 8:5004–5009
Ayata C, Jin H, Kudo C, Dalkara T, Moskowitz MA (2006) Supression of cortical spreading depression in migraine prophylaxis. Ann Neurol 59:652–661
Olesen J, Thomsen LL, Lassen LH, Olesen IJ (1995) The nitric oxide hypothesis of migraine and other vascular headaches. Cephalalgia 15:94–100
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
This study was approved by the Local Ethics Committee of Trakya University Faculty of Medicine. The committee’s registration number is TUTFEK 2008/114. A signed informed consent was obtained from all the subjects prior to participation. All procedures performed were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Funding
The authors received no financial support.
Conflict of interests
The authors declare that they have no conflicts of interest.
Rights and permissions
About this article
Cite this article
Reyhani, A., Celik, Y., Karadag, H. et al. High asymmetric dimethylarginine, symmetric dimethylarginine and L-arginine levels in migraine patients. Neurol Sci 38, 1287–1291 (2017). https://doi.org/10.1007/s10072-017-2970-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-017-2970-1